Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Bone Marrow Mesenchymal Stem Cell Derived Extracellular Vesicles Infusion Treatment: Expanded Access Protocol for Patients With COVID-19 Associated ARDS

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT04657458
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:27:06.522631+00:00
Published At
2024-11-22T00:00:00+00:00
Record Updated At
2024-11-22
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Covid19", "ARDS", "Hypoxia", "Cytokine Storm"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2024-11-22"
protocolSection.identificationModule.nctId
"NCT04657458"
protocolSection.identificationModule.officialTitle
"Bone Marrow Mesenchymal Stem Cell Derived Extracellular Vesicles Infusion Treatment: Expanded Access Protocol for Patients With COVID-19 Associated ARDS"
protocolSection.statusModule.overallStatus
"NO_LONGER_AVAILABLE"
protocolSection.designModule.phases
[]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Covid19 (protocolSection.conditionsModule.conditions)
  • ARDS (protocolSection.conditionsModule.conditions)
  • Hypoxia (protocolSection.conditionsModule.conditions)
  • Cytokine Storm (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.